Polyrizon Ltd. (NASDAQ:PLRZ) Short Interest Update

Polyrizon Ltd. (NASDAQ:PLRZ) was the target of a large increase in short interest in the month of August. As of August 14th, there was short interest totaling 94,216 shares, an increase of 48.8% from the July 30th total of 63,322 shares. Based on an average daily trading volume, of 59,143 shares, the short-interest ratio is currently 1.6 days. Approximately 4.5% of the company’s shares are short sold.

Polyrizon Stock Down 4.1%

Shares of NASDAQ:PLRZ traded down $0.60 during midday trading on Tuesday, reaching $13.91. 162,713 shares of the company’s stock were exchanged, compared to its average volume of 63,364. Polyrizon has a fifty-two week low of $2.88 and a fifty-two week high of $18.20. The firm’s 50 day simple moving average is $12.38 and its two-hundred day simple moving average is $13.11.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the stock. Weiss Ratings raised shares of Polyrizon from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, August 14th. Wall Street Zen upgraded Polyrizon from a “sell” rating to a “hold” rating in a research report on Sunday, June 7th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, Polyrizon currently has an average rating of “Sell”.

Institutional Investors Weigh In On Polyrizon

An institutional investor recently bought a new stake in Polyrizon stock. Jane Street Group LLC purchased a new stake in Polyrizon Ltd. (NASDAQ:PLRZ) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 14,032 shares of the company’s stock, valued at approximately $119,000. Jane Street Group LLC owned 1.35% of Polyrizon as of its most recent filing with the SEC.

About Polyrizon

Polyrizon Ltd. is a development stage biotech company specializing in the development of medical device hydrogels delivered in the form of nasal sprays. Polyrizon Ltd. is based in Raanana, Israel.